欧盟HMA药品数据库（European Union HMA Authorisation of Medicines DataBase）

MR编号	NL/H/0423/002
药品名称	Ceftriaxon Sandoz 1
活性成分	ceftriaxone disodium 1.0 g
剂型	Powder for solution for injection
上市许可持有人	Sandoz BV Veluwezoom 22 NL 1327 AH ALMERE
参考成员国 - 产品名称	Netherlands (NL) Ceftriaxon Sandoz 1, poeder voor oplossing voor injectie/infusie 1 g
互认成员国 - 产品名称	United Kingdom (Northern Ireland) (XI) Austria (AT) Ceftriaxon Sandoz 1 g - Trockenstechampulle Estonia (EE) CEFTRIAXONE SANDOZ Czechia (CZ) Slovakia (SK) Belgium (BE) Portugal (PT)
许可日期	2003/11/18
最近更新日期	2024/04/29
药物ATC编码	J01DD04 ceftriaxone
申请类型	TypeLevel1：Abridged TypeLevel2：Initial Application TypeLevel3：Generic Article 4.8(a)(iii), first paragraph TypeLevel4：Chemical Substance TypeLevel5：Prescription Only
附件文件下载	Final PL \| common-pl ceftriaxon sandozDate of last change:2021/11/11 Final PL \| common-spc ceftriaxon sandozDate of last change:2021/11/11 Final SPC \| common-spcDate of last change:2021/04/26 Final Product Information \| 1.3.1 spc-label-pl - common-SPC - 2,719Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 3,279Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 8,391Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-pl - 8,392Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-outer - 3,280Date of last change:2017/09/12 Final Product Information \| 1.3.1 spc-label-pl - common-SPC - 2,718Date of last change:2017/09/12 Final Labelling \| Labelling NL_H_0423Date of last change:2013/09/16
市场状态	Positive